Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
The lack of effective drug delivery strategies has impaired the therapeutic progress in the treatment of glioblastoma (GBM). Here, the authors engineer synthetic protein nanoparticle based on polymerized human serum albumin equipped with the cell-penetrating peptide iRGD to deliver siRNA against STA...
Guardado en:
Autores principales: | Jason V. Gregory, Padma Kadiyala, Robert Doherty, Melissa Cadena, Samer Habeel, Erkki Ruoslahti, Pedro R. Lowenstein, Maria G. Castro, Joerg Lahann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b30c04bdef1f4073bda6bbf46a097b78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz N, et al.
Publicado: (2020) -
In vivo cation exchange in quantum dots for tumor-specific imaging
por: Xiangyou Liu, et al.
Publicado: (2017) -
Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
por: Natalia Yudintceva, et al.
Publicado: (2021) -
A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries
por: Aman P. Mann, et al.
Publicado: (2016) -
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
por: Dolores Hernán Pérez de la Ossa, et al.
Publicado: (2013)